PillsPharmac
  • Home
Successful Search?
Try one of the below options to narrow down your search.
Google Custom Search:
Loading
PHARMAC Search:

Documents may be browsed by date, eg; Today, June, 2013.

Past years can be browsed too, eg; 2012, 2011, 2010, 2009 ...

Documents can be searched within a period by browsing to the date and then using the search form; or by direct links, eg; Media releases from 2013

Document tags (shown below the document date, eg; Schedule, SAForms, consultation ...) have highest priority when search results are ranked, followed by title, abstract and full text of document.

Parentheses and the keywords and, or and not have special meaning in search terms. And is implicit and can be omitted; or must be specified.

Remember to group or statements with parentheses if they are beside and statements.

Search examples

consultation
Search for consultations
media and not antibiotics
Search for media related documents that don't mention antibiotics.
(media or consultation) and vaccines
Search for media releases and consultation documents mentioning vaccinations.

Search term:

2008 / 12 / 19

PHARMAC documents that matched your search:

Prev, Next – Page 1 of 1 (7 documents)

icon

Changes to prescriber restrictions for acitretin and isotretinoin (4 pages, 190 KB)
2008/12/19
archive, notification

19 December 2008 Changes to prescriber restrictions for acitretin and isotretinoin approved PHARMAC is pleased to announce changes to the prescribing restrictions applying to acitretin and isotretinoin. The changes mean that vocationally registered dermatologists, vocationally registered general practitioners, and nurse…

text


icon

Clinical advice for switching diltiazem patients (3 pages, 105 KB)
2008/12/19
archive, notification

Dear Health Professional Changes to the available preparations of diltiazem hydrochloride As a result of concerns about diltiazem hydrochloride prescribing and dispensing errors, some preparations will be delisted from the Pharmaceutical Schedule from 1 June 2009 as follows: Preparations that…

text


icon

December 2008 Tender results (3 pages, 144 KB)
2008/12/19
archive, notification

FAX Tender Results To: From: Date: All Suppliers and Wholesalers Yvonne Chen 19 December 2008 No of Pages (including this one): 3 Dear Supplier/Wholesaler TENDER RESULTS The PHARMAC Board (or Chief Executive under delegated authority) has resolved to accept a…

text


icon

Extension on consultation on proposal to list solifenacin (Vesicare) and mesalazine (Asamax) - closes 15 January 2009 (1 page, 91 KB)
2008/12/19
archive, consultation

19 December 2008 Consultation on proposal to list solifenacin (Vesicare) and mesalazine (Asamax) in the Pharmaceutical Schedule and to remove restrictions on mesalazine – Extension of response deadline PHARMAC has received requests to extend the deadline for responses to consultation…

text


icon

Patient safety top of mind with acne drug decision (1 page, 66 KB)
2008/12/19
archive, media

19 December 2008 Media release Patient safety `top of mind’ with acne drug decision - PHARMAC Widening access to a medicine used to treat acne has been made with full awareness of patient safety issues, says PHARMAC’s medical director Dr…

text


icon

Post Election Briefing November 2008 (5 pages, 119 KB)
2008/12/19

20 November 2008 Hon Tony Ryall Minister of Health OVERVIEW & KEY ISSUES Copies to PHARMAC Board DHB spokesperson on pharmaceutical issues (Murray Georgel) Director-General of Health (Stephen McKernan) Deputy Director-General, Sector Funding and Performance (Anthony Hill) Recommendations It is…

text


icon

Schedule Update - effective 1 January 2009 (31 pages, 390 KB)
2008/12/19
SchedulePublications, update

Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 January 2009 Section H cumulative for December 2008 and January 2009 Contents Summary of PHARMAC decisions effective 1 January 2009 … 3 Named Specialists for antiretrovirals …. 4 Panadol –…

text


Prev, Next – Page 1 of 1 (7 documents)

New Zealand GovernmentAbout Us | Contact Us